References
- Bernard GR, Artigas A, Brigham KL, et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med. 1994;149(3):818–824.
- Thakur V, Ratho RK, Kumar P, et al. Multi-Organ Involvement in COVID-19: Beyond Pulmonary Manifestations. J Clin Med. 2021;10(3):446.
- Parsons PE, Eisner MD, Thompson BT, et al. Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury. Crit Care Med. 2005;33(1):232.
- Hickling KG. Low volume ventilation with permissive hypercapnia in the Adult Respiratory Distress Syndrome. Clin Intensive Care. 1992;3(2):67–78.
- Máca J, Jor O, Holub M, et al. Past and Present ARDS Mortality Rates: A Systematic Review. Respir Care. 2017;62(1):113–122.
- Horie S, Ansari B, Masterson C, et al. Hypercapnic acidosis attenuates pulmonary epithelial stretch-induced injury via inhibition of the canonical NF-κB pathway. Intensive Care Med Exp. 2016;4(1):8.
- Gibson PG, Qin L, Puah SH. COVID-19 acute respiratory distress syndrome (ARDS): clinical features and differences from typical pre-COVID-19 ARDS. Med J Aust. 2020;213(2):54–56.
- Oppenheimer BW, Bakker J, Goldring RM, et al. Increased Dead Space Ventilation and Refractory Hypercapnia in Patients With Coronavirus Disease 19: A Potential Marker of Thrombosis in the Pulmonary Vasculature. Crit Care Explor. 2020;2(9):e0208.
- Nin N, Angulo M, Briva A. Effects of hypercapnia in acute respiratory distress syndrome. Ann Transl Med. 2018;6(2):37.
- Nin N, Muriel A, Peñuelas O, et al. Severe hypercapnia and outcome of mechanically ventilated patients with moderate or severe acute respiratory distress syndrome. Intensive Care Med. 2017;43(2):200–208.
- Tsonas AM, Botta M, Horn J, et al. Clinical characteristics physiological feature due to COVID-19 insights from Pro VENT-COVID study. J Crit Care Med. 2022; 69: 1–20.
- Matthay MA, Arabi Y, Arroliga AC, et al. A new global definition of acute respiratory distress syndrome. Am J Respir Crit Care Med. 2024 ;209(1):37–47.
- Robins JM, Hernán MA, Brumback B. Marginal structural models and causal inference in epidemiology. Epidemiology. 2000;11(5):550–560.
- Kregenow DA, Rubenfeld GD, Hudson LD, Swenson ER. Hypercapnic acidosis and mortality in acute lung injury. Crit Care Med. 2006;34(1):1–7.
- Maamar A, Delamaire F, Reizine F, et al. Impact of Arterial CO2 Retention in Patients with Moderate or Severe ARDS. Respir Care. 2023;68(5):582–591.
- Tonna JE, Abrams D, Brodie D, et al. Management of Adult Patients Supported with Venovenous Extracorporeal Membrane Oxygenation (VV ECMO): Guideline from the Extracorporeal Life Support Organization (ELSO). ASAIO J. 2021;67(6):601–610.
- Millar JE, Boyle AJ, Drake TM, et al. Extracorporeal carbon dioxide removal in acute hypoxaemic respiratory failure: a systematic review, Bayesian meta-analysis, and trial sequential analysis. Eur Respir Rev. 2022;31(166):1–12.
- Kluis A, Shih E, Squiers JJ, et al. Directed Hypercapnia as a Strategy to Wean Extracorporeal Membrane Oxygenation in COVID-19 Pneumonia. Ann Thorac Surg. 2022;114(5):e307–e309.
- Melberg MB, Flaa A, Andersen, et al. Cardiovascular changes induced by targeted mild hypercapnia after out of hospital cardiac arrest. A sub-study of the TAME cardiac arrest trial. Resuscitation. 2023;193(109970):1–20.
- Liu, X., Jiang, Y., Jia, X. et al. Identification of distinct clinical phenotypes of acute respiratory distress syndrome with differential responses to treatment. Crit Care. 2021;25(320):1–11
- Jaitovich A, Angulo M, Lecuona E, et.al. High CO2 levels cause skeletal muscle atrophy via AMP-activated kinase (AMPK), FoxO3a protein, and muscle-specific Ring finger protein 1 (MuRF1). Journal of Biological Chemistry. 2015;290(14):91–94.
- Kryvenko V, Vadász I. Antianabolic effects of hypercapnia: no country for strong men. American Journal of Respiratory Cell and Molecular Biology. 2020;62(1):8–9.
- Herridge MS, Tansey CM, Matté A, et al. Functional disability 5 years after acute respiratory distress syndrome. N Engl J Med. 2011;364(14):1293–1304.
- Gates KL, Howell HA, Nair A, et al. Hypercapnia impairs lung neutrophil function and increases mortality in murine pseudomonas pneumonia. Am J Respir Cell Mol Biol. 2013;49(5):821–828.
- Roedl K, Jarczak D, Thasler L, et al. Mechanical ventilation, and mortality among 223 critically ill patients with coronavirus disease 2019: A multicentric study in Germany. Aust Crit Care. 2021;34(2):167–175.
- Khan MA, Shahbaz H, Noorali AA, et al. Disparities in adult critical care resources across Pakistan: findings from a national survey and assessment using a novel scoring system. Crit Care. 2022;26(1):209.
- Chaudhry RM, Minhas S, Khan MA, et al. COVID-19 Testing Trend: A Retrospective Analysis of the Three Major Pandemic Waves in Punjab, Pakistan. Cureus. 2024;16(1):e52309.
- Horie S, Gonzalez HE, Laffey JG, Masterson CH. Cell therapy in acute respiratory distress syndrome. J Thorac Dis. 2018;10(9):5607–5620.